Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation

PHASE4CompletedINTERVENTIONAL
Enrollment

1,016

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2020

Study Completion Date

April 30, 2020

Conditions
Aortic Valve DiseaseMyocardial InfarctionStrokeBleeding
Interventions
DRUG

Aspirin + clopidogrel

DRUG

Aspirin monotherapy

DRUG

OAC + clopicogrel

DRUG

OAC monotherapy

Trial Locations (17)

Unknown

Algemeen Stedelijk Ziekenhuis, Aalst

Onze Lieve Vrouwe Ziekenhuis, Aalst

Imelda Ziekenhuis, Bonheiden

Algemeen Ziekenhuis Sint Jan, Bruges

Ziekenhuis Oost-Limburg, Genk

Universitair Ziekenhuis Leuven, Leuven

Charles university, Third Faculty of Medicine, Prague

National Institute Surgery Cardiaque Et De Cardiologie Interventionnelle, Luxembourg

Medisch Spectrum Twente, Enschede

Universitair Medisch Centrum Leiden, Leiden

Haga Ziekenhuis, The Hague

1105 AZ

Academic Medical Centre (AMC), Amsterdam

8011 JW

Isala Clinics, Zwolle

3435CM

St. Antonius Hospital, Nieuwegein

9700 RB

University Medical Center, Groningen

6229 HX

Academic Hospital, Maastricht

3584 CX

University Medical Center Utrecht (UMCU), Utrecht

All Listed Sponsors
lead

St. Antonius Hospital

OTHER

NCT02247128 - Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation | Biotech Hunter | Biotech Hunter